About ARCpoint Labs
ARCpoint Labs is a publicly listed company based in Greenville (United States) founded in 2005. Provider of genetic testing services. Its website arcpointlabs.com draws about 72 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Multiple Application Areas. Its competitors include GreenLight Biosciences, Veritas Genetics and Kailos; 3 of its 3 listed competitors have raised funding.
Company details
ARCpoint Labs was founded in 2005 and is located in Greenville, United States. Genetic testing services are offered within the healthcare and laboratory sector, including paternity tests, background screening, and drug testing for businesses and individuals. Federally mandated testing and DOT-compliant options are also included in the service portfolio, supporting various compliance needs across operations.
- Headquarters Greenville, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website arcpointlabs.com
- Social LinkedIn X Facebook
- Legal Name Arcpoint Inc
- Annual Revenue$618.14 K (USD)-88.78as on Dec 31, 2025
- Net Profit-$2.16 M (USD)-258.92as on Dec 31, 2025
- EBITDA-$2.15 M (USD)37.55as on Dec 31, 2025
- Latest Funding Round$800K (USD), Post-IPO
Mar 2025
Funding Insights of ARCpoint Labs
- Total Rounds 4
- Last Round Post-IPO — $800,000
- First Round $1.1M
(Jan 2024)
All 4 funding rounds of ARCpoint Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $800,000 | Post-IPO | – | – | – |
| Jan 2025 | $554,495 | Post-IPO | – | – | – |
| Jul 2024 | $1M | Post-IPO | – | – | – |
| Jan 2024 | $1.1M | Post-IPO | – | – | – |
People of ARCpoint Labs
26 people are tracked at ARCpoint Labs (13 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Thomas Marlow | President, Arcpoint Of Mid-michigan | Leadership |
John Gallagher III | Director Of Sales And Marketing | Leadership |
John Constantine | President and CEO | Leadership |
Jas Rosales | Compliance Director | Leadership |
Anna Vanhoose | Director Of Franchise Operations & Administration | Leadership |
Tracy Swink | Chief Operations Officer | Leadership |
Rob Sykes | President - Arcpoint Labs Of King Of Prussia | Leadership |
Pritesh Pathak | Director Of Operations | Leadership |
Jamie Welch | Vice President Strategic Initiatives | Leadership |
Tony Waters | VP Training And Compliance | Leadership |
Scott Kondraske | Director Of Operations | Leadership |
Ryan W. | Director Of Corporate Training | Leadership |
Billy Gamble | Director Of Operations | Leadership |
Jason Enda | Operations Manager | Team |
Bernie McNichol | Account Executive | Team |
Laura E. | Administrative Assistant/marketing & Inside Sales | Team |
Michelle Bratcher | Operations | Team |
Kathryn Thayer | Sales And Marketing Representative | Team |
Rhiannon Garratt | Program Manager And Office Administrator | Team |
Ryan Robbins | Medical Assistant | Team |
6 more people are available in the full profile.
Complete people profiles for ARCpoint Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ARCpoint Labs
ARCpoint Labs is a publicly listed company on the TSXV with ticker symbol ARC in Canada, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Jan 2022
- Listed onTSX-V: ARC
- Listed entityARCpoint Inc
- Exchange sectorHealth services
- ISINCA03966D1078
- Share price0.01 CAD · 2026-05-11
- Market capitalisation1,283,588.00 CAD
- EPS (diluted, trailing year)-0.02 CAD
- Volume (last session)1,000
- Analyst consensusNo rating
Financials of ARCpoint Labs
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 846,350 CAD | -3.0M CAD | -3.0M CAD |
| 2024 | 7.5M CAD | 1.9M CAD | -4.7M CAD |
| 2023 | 9.0M CAD | -11.7M CAD | -7.0M CAD |
| 2022 | 14.2M CAD | -10.5M CAD | -4.8M CAD |
| 2021 | 24.0M CAD | 7.2M CAD | 7.2M CAD |
Detailed financial statements for ARCpoint Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ARCpoint Labs
4 dated milestones of ARCpoint Labs across 20 years, from founding to its latest funding, stage changes and deals.
- Founded ARCpoint Labs is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.1M.
- Funding Latest funding round, Post-IPO, of $800K.
Competitors of ARCpoint Labs
ARCpoint Labs has 3 listed competitors in our database, 3 of them funded. They include GreenLight Biosciences, Veritas Genetics and Kailos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| greenlightbiosciences.com | 2008 | Lexington, United States | $225.05M | 287 | RNA-based platform for life sciences is developed by GreenLight Biosciences. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. | |
| kailosgenetics.com | 2010 | Huntsville, United States | $3.9M | 10 | Provider of consumer-based genetic testing services |
Detailed competitors of ARCpoint Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ARCpoint Labs
The website of ARCpoint Labs (arcpointlabs.com) receives about 71.6K visits a month.
- Monthly visits71.6K
▲ 39.7% vs previous month
Websites whose visitors overlap most with ARCpoint Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| anylabtestnow.com | 100% | 226.2K | #165,753 | View details | |
| jcdh.org | 74% | 25.8K | #812,698 | View details | |
| requestatest.com | 74% | #229,182 | View details | ||
| dnacenter.com | 72% | 119.4K | #350,304 | View details | |
usamdt.com | usamdt.com | 71% | #2,006,777 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ARCpoint Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ARCpoint Labs (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arcpoint Labs
Complete news archive for ARCpoint Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ARCpoint Labs
ARCpoint Labs was founded in 2005 and raised its 1st funding round 19 years after it was founded.
ARCpoint Labs is headquartered in Greenville, United States.
Annual revenue of ARCpoint Labs is $618.14K as on Dec 31, 2025.
ARCpoint Labs was founded in 2005 and is located in Greenville, United States. Genetic testing services are offered within the healthcare and laboratory sector, including paternity tests, background screening, and drug testing for businesses and individuals. Federally mandated testing and DOT-compliant options are also included in the service portfolio, supporting various compliance needs across operations.
ARCpoint Labs's top competitors include GreenLight Biosciences, Veritas Genetics and Kailos.
Yes, ARCpoint Labs is publicly traded on TSXV under the ticker symbol ARC.